{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:59:48Z","timestamp":1791187188204,"version":"4.1.0"},"reference-count":391,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.4065\/82.11.1409","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T20:29:19Z","timestamp":1232742559000},"page":"1409-1432","source":"Crossref","is-referenced-by-count":267,"title":["Sarcoma"],"prefix":"10.4065","volume":"82","author":[{"given":"Keith M.","family":"Skubitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"D'Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/82.11.1409_bib1","series-title":"Enzinger and Weiss's Soft Tissue Tumors","author":"Weiss","year":"2001"},{"key":"10.4065\/82.11.1409_bib2","series-title":"Cancer: Principles and Practice of Oncology","first-page":"1841","article-title":"Sarcomas of soft tissue and bone: soft tissue sarcoma","author":"Brennan","year":"2001"},{"key":"10.4065\/82.11.1409_bib3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/cncr.11586","article-title":"Differential gene expression in leiomyosarcoma","volume":"98","author":"Skubitz","year":"2003","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lab.2004.04.005","article-title":"Characterization of sarcomas by means of gene expression","volume":"144","author":"Skubitz","year":"2004","journal-title":"J Lab Clin Med"},{"key":"10.4065\/82.11.1409_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0002-9440(10)63696-6","article-title":"Classification and subtype prediction of adult soft tissue sarcoma by functional genomics","volume":"163","author":"Segal","year":"2003","journal-title":"Am J Pathol"},{"key":"10.4065\/82.11.1409_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(02)08270-3","article-title":"Molecular characterisation of soft tissue tumours: a gene expression study","volume":"359","author":"Nielsen","year":"2002","journal-title":"Lancet"},{"key":"10.4065\/82.11.1409_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2559.2005.02286.x","article-title":"The role of microarray technologies in the study of soft tissue tumours","volume":"48","author":"West","year":"2006","journal-title":"Histopathology"},{"key":"10.4065\/82.11.1409_bib8","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1158\/0008-5472.CAN-05-1699","article-title":"Gene expression profiling of human sarcomas: insights into sarcoma biology","volume":"65","author":"Baird","year":"2005","journal-title":"Cancer Res"},{"key":"10.4065\/82.11.1409_bib9","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1200\/JCO.1996.14.5.1679","article-title":"Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities","volume":"14","author":"Pisters","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib10","first-page":"1941","article-title":"Soft tissue sarcomas of adults: state of the translational science","volume":"9","author":"Borden","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.4065\/82.11.1409_bib11","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJMra041866","article-title":"Soft-tissue sarcomas in adults","volume":"353","author":"Clark","year":"2005","journal-title":"N Engl J Med"},{"key":"10.4065\/82.11.1409_bib12","first-page":"781","article-title":"Update on new diagnostic and therapeutic approaches for sarcomas","volume":"3","author":"Dileo","year":"2005","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.4065\/82.11.1409_bib13","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1084\/jem.12.5.696","article-title":"Sarcoma of the common fowl","volume":"12","author":"Rous","year":"1910","journal-title":"J Exp Med"},{"key":"10.4065\/82.11.1409_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1084\/jem.13.4.397","article-title":"A sarcoma of the fowl transmissible by an agent separable from the tumor cells","volume":"13","author":"Rous","year":"1911","journal-title":"J Exp Med"},{"key":"10.4065\/82.11.1409_bib15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1471-4914(01)02244-4","article-title":"Chromosomal translocations in sarcomas: prospects for therapy","volume":"7","author":"Tomescu","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.4065\/82.11.1409_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.pathol.1.110304.100052","article-title":"Genetics of soft tissue tumors","volume":"1","author":"van de Rijn","year":"2006","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.4065\/82.11.1409_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0165-4608(86)90011-7","article-title":"Cytogenetic studies of adipose tissue tumors, II: recurrent reciprocal translocation t(12;16)(q13;p11) in myxoid liposarcomas","volume":"23","author":"Turc-Carel","year":"1986","journal-title":"Cancer Genet Cytogenet"},{"key":"10.4065\/82.11.1409_bib18","first-page":"1121","article-title":"Chromosomal aberrations in soft tissue tumors: relevance to diagnosis, classification, and molecular mechanisms","volume":"144","author":"Sreekantaiah","year":"1994","journal-title":"Am J Pathol"},{"key":"10.4065\/82.11.1409_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0046-8177(03)00014-5","article-title":"Gene expression analysis of human soft tissue leiomyosarcomas","volume":"34","author":"Ren","year":"2003","journal-title":"Hum Pathol"},{"key":"10.4065\/82.11.1409_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/gcc.20018","article-title":"Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling","volume":"40","author":"Quade","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.4065\/82.11.1409_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/(SICI)1098-2264(199901)24:1<30::AID-GCC5>3.0.CO;2-P","article-title":"Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors","volume":"24","author":"Pedeutour","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.4065\/82.11.1409_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/gcc.2870100203","article-title":"Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma","volume":"10","author":"Pedeutour","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.4065\/82.11.1409_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0165-4608(88)90286-5","article-title":"Chromosomes in Ewing's sarcoma, II: nonrandom additional changes, trisomy 8 and der(16)t(1;16)","volume":"32","author":"Mugneret","year":"1988","journal-title":"Cancer Genet Cytogenet"},{"key":"10.4065\/82.11.1409_bib24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/sj.bjc.6600766","article-title":"Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling","volume":"88","author":"Lee","year":"2003","journal-title":"Br J Cancer"},{"key":"10.4065\/82.11.1409_bib25","first-page":"1229","article-title":"A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1","volume":"10","author":"Jeon","year":"1995","journal-title":"Oncogene"},{"key":"10.4065\/82.11.1409_bib26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199102143240702","article-title":"Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors","volume":"324","author":"Fletcher","year":"1991","journal-title":"N Engl J Med"},{"key":"10.4065\/82.11.1409_bib27","first-page":"623","article-title":"Correlation between clinicopathological features and karyotype in lipomatous tumors: a report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group","volume":"148","author":"Fletcher","year":"1996","journal-title":"Am J Pathol"},{"key":"10.4065\/82.11.1409_bib28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/gcc.2870050403","article-title":"Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11)","volume":"5","author":"Aman","year":"1992","journal-title":"Genes Chromosomes Cancer"},{"key":"10.4065\/82.11.1409_bib29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00001622-200207000-00008","article-title":"Chromosomal translocations and sarcomas","volume":"14","author":"Bennicelli","year":"2002","journal-title":"Curr Opin Oncol"},{"key":"10.4065\/82.11.1409_bib30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/hp.2000.6706","article-title":"Contribution of molecular genetic data to the classification of sarcomas","volume":"31","author":"Ladanyi","year":"2000","journal-title":"Hum Pathol"},{"key":"10.4065\/82.11.1409_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1383-5742(00)00006-5","article-title":"Recurrent chromosome aberrations in cancer","volume":"462","author":"Mitelman","year":"2000","journal-title":"Mutat Res"},{"key":"10.4065\/82.11.1409_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00000421-198910000-00010","article-title":"Radiation-associated sarcoma: a review of 23 patients with postradiation sarcoma over a 50-year period","volume":"12","author":"Amendola","year":"1989","journal-title":"Am J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<6::AID-CNCR2>3.0.CO;2-T","article-title":"Radiation-induced sarcoma\u201450 years later [editorial]","volume":"82","author":"Cahan","year":"1998","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib34","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/1097-0142(1971)28:5<1087::AID-CNCR2820280502>3.0.CO;2-F","article-title":"Radiation-induced sarcoma of bone","volume":"28","author":"Arlen","year":"1971","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/107327489800500505","article-title":"Radiation-induced sarcoma following treatment of breast cancer","volume":"5","author":"Brenin","year":"1998","journal-title":"Cancer Control"},{"key":"10.4065\/82.11.1409_bib36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/1097-0142(19870815)60:4<777::AID-CNCR2820600412>3.0.CO;2-T","article-title":"Radiation-induced angiosarcoma","volume":"60","author":"Nanus","year":"1987","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/1097-0142(19860201)57:3<610::AID-CNCR2820570336>3.0.CO;2-P","article-title":"Radiation-induced sarcomas of the chest wall","volume":"57","author":"Souba","year":"1986","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib38","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/cncr.21531","article-title":"Angiosarcoma of the breast","volume":"104","author":"Vorburger","year":"2005","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1067\/mjd.2002.120909","article-title":"Lymphedema: an immunologically vulnerable site for development of neoplasms","volume":"47","author":"Ruocco","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"2, pt 1","key":"10.4065\/82.11.1409_bib40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0190-9622(98)70237-3","article-title":"Cutaneous vascular proliferations, part III: malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms","volume":"38","author":"Requena","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/82.11.1409_bib41","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/1097-0142(197208)30:2<562::AID-CNCR2820300237>3.0.CO;2-V","article-title":"Lymphangiosarcoma arising in chronic lymphoedematous extremities","volume":"30","author":"Woodward","year":"1972","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib42","first-page":"161","article-title":"Epidemiologic study of workers exposed to vinyl chloride in Porto Marghera: mortality update","volume":"27","author":"Pirastu","year":"2003","journal-title":"Epidemiol Prev"},{"key":"10.4065\/82.11.1409_bib43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/oem.53.7.463","article-title":"Cancer incidence and specific occupational exposures in the Swedish leather tanning industry: a cohort based case-control study","volume":"53","author":"Mikoczy","year":"1996","journal-title":"Occup Environ Med"},{"key":"10.4065\/82.11.1409_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jama.1974.03230390029019","article-title":"Angiosarcoma of the liver following vinyl chloride exposure","volume":"229","author":"Block","year":"1974","journal-title":"JAMA"},{"key":"10.4065\/82.11.1409_bib45","first-page":"163","article-title":"Molecular mechanisms of carcinogenesis by vinyl chloride","volume":"42","author":"Dogliotti","year":"2006","journal-title":"Ann Ist Super Sanita"},{"key":"10.4065\/82.11.1409_bib46","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"10.4065\/82.11.1409_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(02)00263-3","article-title":"Update on Kaposi's sarcoma and other HHV8 associated diseases, part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy","volume":"2","author":"Hengge","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.4065\/82.11.1409_bib48","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF00196354","article-title":"Human herpesvirus-8: detection of novel herpesvirus-like DNA sequences in Kaposi's sarcoma and other lesions","volume":"73","author":"Memar","year":"1995","journal-title":"J Mol Med"},{"key":"10.4065\/82.11.1409_bib49","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(95)91619-9","article-title":"Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma","volume":"346","author":"Whitby","year":"1995","journal-title":"Lancet"},{"key":"10.4065\/82.11.1409_bib50","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1073\/pnas.75.5.2453","article-title":"Model for the incidence of embryonal cancers: application to retinoblastoma","volume":"75","author":"Hethcote","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/82.11.1409_bib51","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/82.11.1409_bib52","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/bjc.1987.200","article-title":"Incidence of second primary tumours among childhood cancer survivors","volume":"56","author":"Hawkins","year":"1987","journal-title":"Br J Cancer"},{"key":"10.4065\/82.11.1409_bib53","first-page":"743","article-title":"Altered patterns of RB expression define groups of soft tissue sarcoma patients with distinct biological and clinical behavior","volume":"21","author":"Polsky","year":"2006","journal-title":"Histol Histopathol"},{"key":"10.4065\/82.11.1409_bib54","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/ijc.22239","article-title":"Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases","volume":"119","author":"Toro","year":"2006","journal-title":"Int J Cancer"},{"key":"10.4065\/82.11.1409_bib55","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/1097-0142(19930715)72:2<486::AID-CNCR2820720226>3.0.CO;2-R","article-title":"Trends in the incidence of soft tissue sarcomas in the United States from 1973 through 1987","volume":"72","author":"Ross","year":"1993","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00000658-199301000-00012","article-title":"Lymph node metastasis from soft tissue sarcoma in adults: analysis of data from a prospective database of 1772 sarcoma patients","volume":"217","author":"Fong","year":"1993","journal-title":"Ann Surg"},{"key":"10.4065\/82.11.1409_bib57","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00000478-200106000-00001","article-title":"Sclerosing epithelioid fibrosarcoma: a study of 16 cases and confirmation of a clinicopathologically distinct tumor","volume":"25","author":"Antonescu","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.4065\/82.11.1409_bib58","series-title":"AJCC Cancer Staging Manual","year":"2002"},{"key":"10.4065\/82.11.1409_bib59","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.20.3.791","article-title":"Postoperative nomogram for 12-year sarcoma-specific death","volume":"20","author":"Kattan","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib60","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.5858\/2006-130-1448-GOSTSR","article-title":"Grading of soft tissue sarcomas: review and update","volume":"130","author":"Coindre","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.4065\/82.11.1409_bib61","volume":"5","year":"2002"},{"key":"10.4065\/82.11.1409_bib62","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/1097-0142(19840201)53:3<530::AID-CNCR2820530327>3.0.CO;2-D","article-title":"The grading of soft tissue sarcomas: results of a clinicohistopathologic correlation in a series of 163 cases","volume":"53","author":"Costa","year":"1984","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib63","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1200\/JCO.1997.15.1.350","article-title":"Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma","volume":"15","author":"Guillou","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib64","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s002560100408","article-title":"Grading in soft tissue tumors: principles and problems","volume":"30","author":"Oliveira","year":"2001","journal-title":"Skeletal Radiol"},{"key":"10.4065\/82.11.1409_bib65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ijc.2910330108","article-title":"Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system","volume":"33","author":"Trojani","year":"1984","journal-title":"Int J Cancer"},{"key":"10.4065\/82.11.1409_bib66","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.hoc.2005.03.001","article-title":"Imaging and response in soft tissue sarcomas","volume":"19","author":"Schuetze","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.4065\/82.11.1409_bib67","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1102\/1470-7330.2005.0007","article-title":"Functional imaging techniques for evaluation of sarcomas","volume":"5","author":"Hicks","year":"2005","journal-title":"Cancer Imaging"},{"key":"10.4065\/82.11.1409_bib68","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.1998.16.1.197","article-title":"Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity","volume":"16","author":"Yang","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib69","series-title":"The Technological Basis of Radiation Therapy: Practical Clinical Applications","article-title":"Extremity soft tissue sarcoma in adults","author":"Dusenbery","year":"1992"},{"key":"10.4065\/82.11.1409_bib70","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/1097-0142(19830801)52:3<424::AID-CNCR2820520307>3.0.CO;2-8","article-title":"Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities","volume":"52","author":"Rosenberg","year":"1983","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib71","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/1097-0142(19810501)47:9<2269::AID-CNCR2820470928>3.0.CO;2-J","article-title":"Preoperative radiation therapy for sarcoma of soft tissue","volume":"47","author":"Suit","year":"1981","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib72","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jso.2930520405","article-title":"Preoperative radiation, surgical margins, and local control of extremity sarcomas of soft tissues","volume":"52","author":"Sadoski","year":"1993","journal-title":"J Surg Oncol"},{"key":"10.4065\/82.11.1409_bib73","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","article-title":"Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial","volume":"359","author":"O'Sullivan","year":"2002","journal-title":"Lancet"},{"key":"10.4065\/82.11.1409_bib74","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1200\/JCO.2002.03.084","article-title":"Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma","volume":"20","author":"Davis","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib75","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(97)08165-8","article-title":"Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data","volume":"350","author":"Sarcoma Meta-analysis Collaboration","year":"1997","journal-title":"Lancet"},{"key":"10.4065\/82.11.1409_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001419","article-title":"Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults","author":"Sarcoma Meta-analysis Collaboration (SMAC)","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.4065\/82.11.1409_bib77","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1200\/JCO.2001.19.5.1238","article-title":"Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial","volume":"19","author":"Frustaci","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib78","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/00000421-200210000-00009","article-title":"Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcoma","volume":"25","author":"Petrioli","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib79","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1200\/JCO.2004.02.057","article-title":"Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes","volume":"22","author":"Cormier","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib80","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11912-004-0041-2","article-title":"Role of gene expression arrays in sarcomas","volume":"6","author":"Skubitz","year":"2004","journal-title":"Curr Oncol Rep"},{"key":"10.4065\/82.11.1409_bib81","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0277-5379(89)90135-1","article-title":"Doxorubicin: effect of different schedules on toxicity and anti-tumor efficacy","volume":"25","author":"Bielack","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.4065\/82.11.1409_bib82","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-96-2-133","article-title":"Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion","volume":"96","author":"Legha","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.4065\/82.11.1409_bib83","first-page":"971","article-title":"Continuous venous infusion of doxorubicin in advanced sarcomas","volume":"71","author":"Samuels","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"10.4065\/82.11.1409_bib84","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/1097-0142(19900215)65:4<870::AID-CNCR2820650407>3.0.CO;2-D","article-title":"Reduced cardiotoxicity of doxorubicin by a 6-hour infusion regimen: a prospective randomized evaluation","volume":"65","author":"Shapira","year":"1990","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib85","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/jnci\/83.13.926","article-title":"Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study","volume":"83","author":"Zalupski","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.4065\/82.11.1409_bib86","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/j.1552-4604.1996.tb04152.x","article-title":"Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma","volume":"36","author":"Northfelt","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.4065\/82.11.1409_bib87","first-page":"51","article-title":"Stealth liposomal doxorubicin (SLD) delivers more doxorubicin (DOX) to AIDS-related Kaposi's sarcoma (AIDS-KS) lesions than to normal skin [abstract 5]","volume":"13","author":"Northfelt","year":"1994","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.4065\/82.11.1409_bib88","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/j.seminoncol.2004.08.010","article-title":"Efficacy and safety of liposomal anthracyclines in phase I\/II clinical trials","volume":"31","author":"Alberts","year":"2004","journal-title":"Semin Oncol"},{"key":"10.4065\/82.11.1409_bib89","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0959-8049(01)00050-8","article-title":"Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL\/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group","volume":"37","author":"Judson","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.4065\/82.11.1409_bib90","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1081\/CNV-120016412","article-title":"Phase II trial of pegylated-liposomal doxorubicin (Doxil) in sarcoma","volume":"21","author":"Skubitz","year":"2003","journal-title":"Cancer Invest"},{"key":"10.4065\/82.11.1409_bib91","first-page":"485","article-title":"Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG)","volume":"20","author":"Toma","year":"2000","journal-title":"Anticancer Res"},{"key":"10.4065\/82.11.1409_bib92","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/1097-0142(197212)30:6<1632::AID-CNCR2820300632>3.0.CO;2-S","article-title":"Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide","volume":"30","author":"Gottlieb","year":"1972","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib93","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/01.cad.0000127331.29310.8a","article-title":"Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers","volume":"15","author":"Awada","year":"2004","journal-title":"Anticancer Drugs"},{"key":"10.4065\/82.11.1409_bib94","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1200\/JCO.1993.11.7.1269","article-title":"Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas","volume":"11","author":"Edmonson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib95","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00000421-199806000-00025","article-title":"Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas","volume":"21","author":"Patel","year":"1998","journal-title":"Am J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib96","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1023\/A:1008279426654","article-title":"Phase II study of continuous-infusion high-dose ifosfamide in advanced and\/or metastatic pretreated soft tissue sarcomas","volume":"8","author":"Palumbo","year":"1997","journal-title":"Ann Oncol"},{"key":"10.4065\/82.11.1409_bib97","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1002\/1097-0142(19931115)72:10<2963::AID-CNCR2820721017>3.0.CO;2-W","article-title":"Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas","volume":"72","author":"Skubitz","year":"1993","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib98","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00000421-199412000-00005","article-title":"Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas","volume":"17","author":"Blair","year":"1994","journal-title":"Am J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib99","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0959-8049(99)00240-3","article-title":"Effect of high-dose ifosfamide in advanced soft tissue sarcomas: a multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group","volume":"36","author":"Nielsen","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.4065\/82.11.1409_bib100","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1200\/JCO.1997.15.6.2378","article-title":"High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies\u2014dose-response and schedule dependence","volume":"15","author":"Patel","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib101","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1002\/cncr.10602","article-title":"Phase II trial of gemcitabine in advanced sarcomas","volume":"94","author":"Okuno","year":"2002","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib102","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/cncr.11290","article-title":"Phase II trial of gemcitabine in patients with advanced sarcomas (E1797): a trial of the Eastern Cooperative Oncology Group","volume":"97","author":"Okuno","year":"2003","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib103","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1200\/JCO.2001.19.15.3483","article-title":"Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation","volume":"19","author":"Patel","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib104","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ygyno.2003.11.023","article-title":"Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study","volume":"92","author":"Look","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.4065\/82.11.1409_bib105","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0959-8049(01)00408-7","article-title":"Gemcitabine in advanced adult soft-tissue sarcomas: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group","volume":"38","author":"Svancarova","year":"2002","journal-title":"Eur J Cancer"},{"issue":"suppl","key":"10.4065\/82.11.1409_bib106","first-page":"18S","article-title":"A SARC multicenter phase III study of gemcitabine (G) vs. gemcitabine and docetaxel (G+D) in patients (pts) with metastatic soft tissue sarcomas (STS) [abstract 9514]","volume":"24","author":"Maki","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib107","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0026-895X(25)09518-5","article-title":"Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2\u2032,2\u2032-difluorodeoxycytidine","volume":"38","author":"Heinemann","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.4065\/82.11.1409_bib108","first-page":"6110","article-title":"Action of 2\u2032,2\u2032-difluorodeoxycytidine on DNA synthesis","volume":"51","author":"Huang","year":"1991","journal-title":"Cancer Res"},{"issue":"5, suppl 10","key":"10.4065\/82.11.1409_bib109","first-page":"3","article-title":"Gemcitabine: preclinical pharmacology and mechanisms of action","volume":"23","author":"Plunkett","year":"1996","journal-title":"Semin Oncol"},{"key":"10.4065\/82.11.1409_bib110","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF00685109","article-title":"Saturation of 2\u2032,2\u2032-difluorodeoxycytidine 5\u2032-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine","volume":"27","author":"Grunewald","year":"1991","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.4065\/82.11.1409_bib111","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.1991.9.3.491","article-title":"A phase I clinical, plasma, and cellular pharmacology study of gemcitabine","volume":"9","author":"Abbruzzese","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib112","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1200\/JCO.2002.11.050","article-title":"Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial","volume":"20","author":"Hensley","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib113","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1021\/ed083p728","article-title":"The discovery and development of cisplatin","volume":"83","author":"Alderden","year":"2006","journal-title":"J Chem Educ"},{"key":"10.4065\/82.11.1409_bib114","first-page":"1799","article-title":"The successful regression of large solid sarcoma 180 tumors by platinum compounds","volume":"30","author":"Rosenberg","year":"1970","journal-title":"Cancer Res"},{"key":"10.4065\/82.11.1409_bib115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: a new class of potent antitumour agents","volume":"222","author":"Rosenberg","year":"1969","journal-title":"Nature"},{"key":"10.4065\/82.11.1409_bib116","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00257535","article-title":"Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas","volume":"15","author":"Edmonson","year":"1985","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.4065\/82.11.1409_bib117","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/cncr.10259","article-title":"Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor","volume":"94","author":"Edmonson","year":"2002","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib118","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2034::AID-CNCR21>3.0.CO;2-P","article-title":"Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face","volume":"86","author":"Fata","year":"1999","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib119","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/cncr.21140","article-title":"Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma","volume":"104","author":"Skubitz","year":"2005","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib120","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1200\/JCO.2005.01.180","article-title":"Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial [published correction appears in J Clin Oncol. 2005;23:5276]","volume":"23","author":"Le Cesne","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib121","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1200\/JCO.2005.05.028","article-title":"Ecteinascidin-743 (ET-743) for chemotherapy-naive patients with advanced soft tissue sarcomas: multicenter phase II and pharmacokinetic study","volume":"23","author":"Garcia-Carbonero","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib122","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1200\/JCO.1993.11.7.1276","article-title":"An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas","volume":"11","author":"Antman","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib123","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1200\/JCO.1995.13.7.1537","article-title":"Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group","volume":"13","author":"Santoro","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib124","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1200\/JCO.1989.7.9.1208","article-title":"Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy","volume":"7","author":"Elias","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib125","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/1097-0142(19931101)72:9<2593::AID-CNCR2820720914>3.0.CO;2-D","article-title":"Measurement and prediction of the short-term response of soft tissue sarcomas to chemotherapy","volume":"72","author":"Schmidt","year":"1993","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib126","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1002\/1097-0142(19911201)68:11<2354::AID-CNCR2820681104>3.0.CO;2-S","article-title":"Does histologic grade in soft tissue sarcoma influence response rate to systemic chemotherapy?","volume":"68","author":"van Haelst-Pisani","year":"1991","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib127","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1634\/theoncologist.11-1-65","article-title":"How to treat the Ewing's family of sarcomas in adult patients","volume":"11","author":"Scurr","year":"2006","journal-title":"Oncologist"},{"key":"10.4065\/82.11.1409_bib128","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJM199907293410507","article-title":"Common musculoskeletal tumors of childhood and adolescence","volume":"341","author":"Arndt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.4065\/82.11.1409_bib129","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1038\/sj.onc.1208060","article-title":"Prediction of high risk Ewing's sarcoma by gene expression profiling","volume":"23","author":"Ohali","year":"2004","journal-title":"Oncogene"},{"key":"10.4065\/82.11.1409_bib130","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/1097-0142(197204)29:4<961::AID-CNCR2820290443>3.0.CO;2-A","article-title":"Fibroxanthosarcoma of the soft tissues: a type of malignant fibrous histiocytoma","volume":"29","author":"Kempson","year":"1972","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib131","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1823::AID-CNCR10>3.0.CO;2-1","article-title":"Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis","volume":"77","author":"Le Doussal","year":"1996","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib132","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1002\/1097-0142(19920415)69:8<2098::AID-CNCR2820690815>3.0.CO;2-9","article-title":"Prognostic factors in 227 patients with malignant fibrous histiocytoma","volume":"69","author":"Pezzi","year":"1992","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib133","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/1097-0142(19910115)67:2<499::AID-CNCR2820670230>3.0.CO;2-E","article-title":"Malignant fibrous histiocytoma of soft tissue: a population-based epidemiologic and prognostic study of 137 patients","volume":"67","author":"Rooser","year":"1991","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib134","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00000478-198212000-00009","article-title":"Malignant fibrous histiocytoma: a reaffirmation","volume":"6","author":"Weiss","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.4065\/82.11.1409_bib135","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1200\/JCO.2001.19.12.3045","article-title":"Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification","volume":"19","author":"Fletcher","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib136","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00000478-199203000-00001","article-title":"Pleomorphic malignant fibrous histiocytoma: fact or fiction? a critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma","volume":"16","author":"Fletcher","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.4065\/82.11.1409_bib137","first-page":"236","article-title":"Malignant fibrous histiocytoma: nonspecific morphologic pattern, specific pathologic entity, or both?","volume":"112","author":"Dehner","year":"1988","journal-title":"Arch Pathol Lab Med"},{"key":"10.4065\/82.11.1409_bib138","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","article-title":"Cancer statistics, 2006","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"10.4065\/82.11.1409_bib139","first-page":"3977","article-title":"Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases","volume":"7","author":"Antonescu","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.4065\/82.11.1409_bib140","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/1097-0142(19891001)64:7<1514::AID-CNCR2820640726>3.0.CO;2-2","article-title":"The prognostic value of histologic subtypes in primary extremity liposarcoma","volume":"64","author":"Chang","year":"1989","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib141","first-page":"329","article-title":"The management of retroperitoneal soft tissue sarcoma","volume":"33","author":"Lewis","year":"1999","journal-title":"Adv Surg"},{"key":"10.4065\/82.11.1409_bib142","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archsurg.134.2.190","article-title":"Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma","volume":"134","author":"Lewis","year":"1999","journal-title":"Arch Surg"},{"key":"10.4065\/82.11.1409_bib143","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00000478-200205000-00006","article-title":"Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group","volume":"26","author":"Gebhard","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.4065\/82.11.1409_bib144","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00199383","article-title":"Lipomatous tumours of soft tissues: an update","volume":"427","author":"Mentzel","year":"1995","journal-title":"Virchows Arch"},{"key":"10.4065\/82.11.1409_bib145","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.sla.0000234795.98607.00","article-title":"Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk","volume":"244","author":"Dalal","year":"2006","journal-title":"Ann Surg"},{"key":"10.4065\/82.11.1409_bib146","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0165-4608(96)00436-0","article-title":"Overrepresentation of 1q21-23 and 12q13-21 in lipoma-like liposarcomas but not in benign lipomas: a comparative genomic hybridization study","volume":"99","author":"Szymanska","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.4065\/82.11.1409_bib147","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0165-4608(95)00164-6","article-title":"Mapping of the translocation breakpoints of primary pleomorphic adenomas and lipomas within a common region of chromosome 12","volume":"86","author":"Wanschura","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.4065\/82.11.1409_bib148","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.nu.14.070194.000531","article-title":"Regulation of adipocyte development","volume":"14","author":"Cornelius","year":"1994","journal-title":"Annu Rev Nutr"},{"key":"10.4065\/82.11.1409_bib149","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nrm2066","article-title":"Adipocyte differentiation from the inside out","volume":"7","author":"Rosen","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.4065\/82.11.1409_bib150","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2006.07.085","article-title":"A novel type of EWS-CHOP fusion gene in myxoid liposarcoma","volume":"348","author":"Matsui","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.4065\/82.11.1409_bib151","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1073\/pnas.96.9.5025","article-title":"Induction of a secreted protein by the myxoid liposarcoma oncogene","volume":"96","author":"Kuroda","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/82.11.1409_bib152","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ajcp\/103.1.20","article-title":"Cytogenetic and immunohistochemical profile of myxoid liposarcoma","volume":"103","author":"Gibas","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/82.11.1409_bib153","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/363640a0","article-title":"Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma","volume":"363","author":"Crozat","year":"1993","journal-title":"Nature"},{"key":"10.4065\/82.11.1409_bib154","doi-asserted-by":"crossref","first-page":"15574","DOI":"10.1074\/jbc.273.25.15574","article-title":"Human translocation liposarcoma-CCAAT\/enhancer binding protein (C\/EBP) homologous protein (TLS-CHOP) oncoprotein prevents adipocyte differentiation by directly interfering with C\/EBPbeta function","volume":"273","author":"Adelmant","year":"1998","journal-title":"J Biol Chem"},{"key":"10.4065\/82.11.1409_bib155","doi-asserted-by":"crossref","first-page":"13395","DOI":"10.1074\/jbc.M011176200","article-title":"Involvement of the prooncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator","volume":"276","author":"Uranishi","year":"2001","journal-title":"J Biol Chem"},{"key":"10.4065\/82.11.1409_bib156","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/gcc.2870090406","article-title":"MDM2 gene amplification correlates with ring chromosome in soft tissue tumors","volume":"9","author":"Nilbert","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.4065\/82.11.1409_bib157","first-page":"345","article-title":"Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas","volume":"145","author":"Latres","year":"1994","journal-title":"Am J Pathol"},{"key":"10.4065\/82.11.1409_bib158","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1096-9896(199701)181:1<14::AID-PATH730>3.0.CO;2-O","article-title":"Distinct mdm2\/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms","volume":"181","author":"Pilotti","year":"1997","journal-title":"J Pathol"},{"key":"10.4065\/82.11.1409_bib159","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/(SICI)1096-9896(199806)185:2<188::AID-PATH53>3.0.CO;2-2","article-title":"Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22","volume":"185","author":"Pilotti","year":"1998","journal-title":"J Pathol"},{"key":"10.4065\/82.11.1409_bib160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1073\/pnas.94.1.237","article-title":"Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor","volume":"94","author":"Tontonoz","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/82.11.1409_bib161","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1073\/pnas.96.7.3951","article-title":"Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma","volume":"96","author":"Demetri","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/82.11.1409_bib162","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/sj.bjc.6601306","article-title":"A phase II trial with rosiglitazone in liposarcoma patients","volume":"89","author":"Debrock","year":"2003","journal-title":"Br J Cancer"},{"key":"10.4065\/82.11.1409_bib163","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.cco.0000228743.72165.86","article-title":"Future directions for immunotherapeutic intervention against sarcomas","volume":"18","author":"Maki","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.4065\/82.11.1409_bib164","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1081\/CNV-50432","article-title":"Differential gene expression in liposarcoma, lipoma, and adipose tissue","volume":"23","author":"Skubitz","year":"2005","journal-title":"Cancer Invest"},{"key":"10.4065\/82.11.1409_bib165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/(SICI)1097-0142(19970715)80:2<211::AID-CNCR7>3.0.CO;2-W","article-title":"Molecular determination of the malignant potential of smooth muscle neoplasms","volume":"80","author":"Trzyna","year":"1997","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib166","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0304-3835(00)00607-8","article-title":"Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction","volume":"164","author":"Miyajima","year":"2001","journal-title":"Cancer Lett"},{"key":"10.4065\/82.11.1409_bib167","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0002-9440(10)65441-7","article-title":"Correlation between clinicopathological features and karyotype in spindle cell sarcomas: a report of 130 cases from the CHAMP study group","volume":"154","author":"Fletcher","year":"1999","journal-title":"Am J Pathol"},{"key":"10.4065\/82.11.1409_bib168","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cncr.22395","article-title":"Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group","volume":"109","author":"Svarvar","year":"2007","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib169","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ng0894-502","article-title":"Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma","volume":"7","author":"Clark","year":"1994","journal-title":"Nat Genet"},{"key":"10.4065\/82.11.1409_bib170","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/j.1460-2075.1995.tb07228.x","article-title":"Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma","volume":"14","author":"Crew","year":"1995","journal-title":"EMBO J"},{"key":"10.4065\/82.11.1409_bib171","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/jnci\/91.11.974","article-title":"A novel fusion gene, SYT-SSX4, in synovial sarcoma","volume":"91","author":"Skytting","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.4065\/82.11.1409_bib172","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/labinvest.3780085","article-title":"Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma","volume":"80","author":"Mancuso","year":"2000","journal-title":"Lab Invest"},{"key":"10.4065\/82.11.1409_bib173","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1054\/bjoc.2001.2088","article-title":"SYT-SSX fusion genes and prognosis in synovial sarcoma","volume":"85","author":"Mezzelani","year":"2001","journal-title":"Br J Cancer"},{"key":"10.4065\/82.11.1409_bib174","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1002\/1097-0142(19940515)73:10<2506::AID-CNCR2820731009>3.0.CO;2-S","article-title":"Synovial sarcoma: uniform response of metastases to high dose ifosfamide","volume":"73","author":"Rosen","year":"1994","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib175","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1073\/pnas.0437972100","article-title":"Immunomic analysis of human sarcoma","volume":"100","author":"Lee","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/82.11.1409_bib176","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/1097-0142(19870301)59:5<1046::AID-CNCR2820590533>3.0.CO;2-6","article-title":"Angiosarcoma of the face and scalp, prognosis and treatment","volume":"59","author":"Holden","year":"1987","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib177","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1200\/JCO.1997.15.4.1708","article-title":"Angiosarcoma","volume":"15","author":"Vonderheide","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib178","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2400::AID-CNCR32>3.0.CO;2-Z","article-title":"Angiosarcoma: a report of 67 patients and a review of the literature","volume":"77","author":"Mark","year":"1996","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib179","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1365-2230.1997.2050612.x","article-title":"Postirradiation angiosarcoma","volume":"22","author":"Stone","year":"1997","journal-title":"Clin Exp Dermatol"},{"key":"10.4065\/82.11.1409_bib180","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00001813-199710000-00002","article-title":"A phase I study of ambulatory continuous infusion paclitaxel","volume":"8","author":"Skubitz","year":"1997","journal-title":"Anticancer Drugs"},{"key":"10.4065\/82.11.1409_bib181","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s004320000221","article-title":"Angiosarcoma of the scalp: treatment with liposomal doxorubicin and radiotherapy","volume":"127","author":"Wollina","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.4065\/82.11.1409_bib182","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1468-3083.1996.tb00138.x","article-title":"Cutaneous angiosarcoma: a novel therapy with liposomal doxorubicin?","volume":"6","author":"Ockenfels","year":"1996","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.4065\/82.11.1409_bib183","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/clon.1999.9046","article-title":"Complete resolution of angiosarcoma of the scalp with liposomal daunorubicin and radiotherapy","volume":"11","author":"Lankester","year":"1999","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.4065\/82.11.1409_bib184","first-page":"1187","article-title":"Regression of metastatic angiosarcoma of the skin after systemic treatment with liposome-encapsulated doxorubicin and interferon-alpha","volume":"140","author":"Jackel","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.4065\/82.11.1409_bib185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00130404-200505000-00011","article-title":"A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy [published correction appears in Cancer J .2005;11:354]","volume":"11","author":"Fury","year":"2005","journal-title":"Cancer J"},{"key":"10.4065\/82.11.1409_bib186","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1365-2133.2002.04726.x","article-title":"Complete remission of a radio-resistant cutaneous angiosarcoma of the scalp by systemic treatment with liposomal doxorubicin","volume":"147","author":"Eiling","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.4065\/82.11.1409_bib187","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3109\/07357909809011697","article-title":"Phase II trial of paclitaxel in patients with soft-tissue sarcoma","volume":"16","author":"Casper","year":"1998","journal-title":"Cancer Invest"},{"key":"10.4065\/82.11.1409_bib188","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/bmj.308.6939.1303b","article-title":"Original description of Kaposi's sarcoma [letter]","volume":"308","author":"Breimer","year":"1994","journal-title":"BMJ"},{"key":"10.4065\/82.11.1409_bib189","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01830024","article-title":"Idiopathisches multiples pigmentsarkom der Haut","volume":"4","author":"Kaposi","year":"1872","journal-title":"Arch Dermatol Syph"},{"issue":"3","key":"10.4065\/82.11.1409_bib190","first-page":"345","article-title":"Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma","volume":"2","author":"Udhrain","year":"2007","journal-title":"Int J Nanomed"},{"key":"10.4065\/82.11.1409_bib191","first-page":"867","article-title":"AIDS-related Kaposi's sarcoma: current treatment options, future trends","volume":"14","author":"Mitsuyasu","year":"2000","journal-title":"Oncology (Williston Park)"},{"key":"10.4065\/82.11.1409_bib192","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0025-6196(11)63945-1","article-title":"Acquired immunodeficiency syndrome-related Kaposi's sarcoma","volume":"70","author":"Wang","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/82.11.1409_bib193","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.302.6770.203","article-title":"Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS","volume":"302","author":"Peters","year":"1991","journal-title":"BMJ"},{"key":"10.4065\/82.11.1409_bib194","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.seminoncol.2004.08.003","article-title":"Use of liposomal anthracyclines in Kaposi's sarcoma","volume":"31","author":"Krown","year":"2004","journal-title":"Semin Oncol"},{"key":"10.4065\/82.11.1409_bib195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2004.08.064","article-title":"Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma","volume":"22","author":"Krown","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib196","series-title":"Doxil (doxorubicin HCI liposome injection) [prescribing information]","year":"2001"},{"key":"10.4065\/82.11.1409_bib197","series-title":"DaunoXome (daunorubicin citrate liposome injection) [prescribing information]","year":"1996"},{"key":"10.4065\/82.11.1409_bib198","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1200\/JCO.1997.15.2.653","article-title":"Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy","volume":"15","author":"Northfelt","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib199","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.1998.16.7.2445","article-title":"Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial","volume":"16","author":"Northfelt","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib200","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.1998.16.2.683","article-title":"Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma","volume":"16","author":"Stewart","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib201","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1081\/CNV-100104284","article-title":"Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma: a randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine","volume":"19","author":"Osoba","year":"2001","journal-title":"Cancer Invest"},{"key":"10.4065\/82.11.1409_bib202","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1200\/JCO.1996.14.8.2353","article-title":"Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma","volume":"14","author":"Gill","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib203","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.1999.17.6.1876","article-title":"Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma","volume":"17","author":"Gill","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib204","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/cncr.21791","article-title":"Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection","volume":"106","author":"Fardet","year":"2006","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib205","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(95)92654-2","article-title":"Treatment of HIV-associated Kaposi's sarcoma with paclitaxel","volume":"346","author":"Saville","year":"1995","journal-title":"Lancet"},{"key":"10.4065\/82.11.1409_bib206","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.1998.16.3.1112","article-title":"Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma","volume":"16","author":"Welles","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib207","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/hupa.2002.123545","article-title":"Diagnosis of gastrointestinal stromal tumors: a consensus approach","volume":"33","author":"Fletcher","year":"2002","journal-title":"Hum Pathol"},{"key":"10.4065\/82.11.1409_bib208","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1470-2045(02)00899-9","article-title":"Management of malignant gastrointestinal stromal tumours","volume":"3","author":"Joensuu","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.4065\/82.11.1409_bib209","first-page":"3","article-title":"Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics","volume":"54","author":"Miettinen","year":"2003","journal-title":"Pol J Pathol"},{"key":"10.4065\/82.11.1409_bib210","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00000478-199904000-00002","article-title":"Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors","volume":"23","author":"Sircar","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.4065\/82.11.1409_bib211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1679\/aohc.65.1","article-title":"The interstitial cells of Cajal and a gastroenteric pacemaker system","volume":"65","author":"Takayama","year":"2002","journal-title":"Arch Histol Cytol"},{"key":"10.4065\/82.11.1409_bib212","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.5858\/2000-124-1471-COOGST","article-title":"Cellular origin of gastrointestinal stromal tumors: a study of 27 cases","volume":"124","author":"Wang","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.4065\/82.11.1409_bib213","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00000478-199901000-00009","article-title":"Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site","volume":"23","author":"Emory","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.4065\/82.11.1409_bib214","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"10.4065\/82.11.1409_bib215","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1073\/pnas.1037763100","article-title":"Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase","volume":"100","author":"Sommer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/82.11.1409_bib216","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM200104053441404","article-title":"Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor","volume":"344","author":"Joensuu","year":"2001","journal-title":"N Engl J Med"},{"key":"10.4065\/82.11.1409_bib217","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1079666","article-title":"PDGFRA activating mutations in gastrointestinal stromal tumors","volume":"299","author":"Heinrich","year":"2003","journal-title":"Science"},{"key":"10.4065\/82.11.1409_bib218","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/1209","article-title":"Familial gastrointestinal stromal tumours with germline mutation of the KIT gene","volume":"19","author":"Nishida","year":"1998","journal-title":"Nat Genet"},{"key":"10.4065\/82.11.1409_bib219","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/hupa.2002.124124","article-title":"Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations","volume":"33","author":"Heinrich","year":"2002","journal-title":"Hum Pathol"},{"key":"10.4065\/82.11.1409_bib220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02256550","article-title":"Biological significance of chromosomal imbalance aberrations in gastrointestinal stromal tumors","volume":"11","author":"Chen","year":"2004","journal-title":"J Biomed Sci"},{"key":"10.4065\/82.11.1409_bib221","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000658-200001000-00008","article-title":"Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival","volume":"231","author":"DeMatteo","year":"2000","journal-title":"Ann Surg"},{"key":"10.4065\/82.11.1409_bib222","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1200\/JCO.2005.05.3439","article-title":"Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors","volume":"24","author":"Raut","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib223","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.4065\/82.11.1409_bib224","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1200\/JCO.2004.05.140","article-title":"Biology of gastrointestinal stromal tumors","volume":"22","author":"Corless","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib225","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1081\/CNV-200055972","article-title":"State-of-the art therapy for gastrointestinal stromal tumors","volume":"23","author":"Blanke","year":"2005","journal-title":"Cancer Invest"},{"key":"10.4065\/82.11.1409_bib226","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(04)17098-0","article-title":"Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial","volume":"364","author":"Verweij","year":"2004","journal-title":"Lancet"},{"key":"10.4065\/82.11.1409_bib227","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(06)69446-4","article-title":"Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial","volume":"368","author":"Demetri","year":"2006","journal-title":"Lancet"},{"key":"10.4065\/82.11.1409_bib228","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/01.cco.0000228747.02660.e2","article-title":"New developments in gastrointestinal stromal tumor","volume":"18","author":"Trent","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.4065\/82.11.1409_bib229","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1200\/JCO.2006.06.2265","article-title":"Molecular correlates of imatinib resistance in gastrointestinal stromal tumors","volume":"24","author":"Heinrich","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib230","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","article-title":"Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor","volume":"21","author":"Heinrich","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib231","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00280-002-0564-x","article-title":"Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT","volume":"51","author":"Bauer","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.4065\/82.11.1409_bib232","first-page":"357","article-title":"Comparison of PET, CT, and dualmodality PET\/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors","volume":"45","author":"Antoch","year":"2004","journal-title":"J Nucl Med"},{"key":"10.4065\/82.11.1409_bib233","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2214\/ajr.183.6.01831619","article-title":"CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings","volume":"183","author":"Choi","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.4065\/82.11.1409_bib234","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0959-8049(03)00073-X","article-title":"18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec)","volume":"39","author":"Stroobants","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.4065\/82.11.1409_bib235","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ejca.2006.01.026","article-title":"RECIST revisited: a review of validation studies on tumour assessment","volume":"42","author":"Therasse","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.4065\/82.11.1409_bib236","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/ijc.10535","article-title":"Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans","volume":"100","author":"Maki","year":"2002","journal-title":"Int J Cancer"},{"key":"10.4065\/82.11.1409_bib237","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00019606-199704000-00005","article-title":"Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder","volume":"6","author":"Alman","year":"1997","journal-title":"Diagn Mol Pathol"},{"key":"10.4065\/82.11.1409_bib238","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01241398-199201000-00001","article-title":"Aggressive fibromatosis","volume":"12","author":"Alman","year":"1992","journal-title":"J Pediatr Orthop"},{"key":"10.4065\/82.11.1409_bib239","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/1097-0215(20010320)95:2<102::AID-IJC1018>3.0.CO;2-8","article-title":"Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis","volume":"95","author":"Bertario","year":"2001","journal-title":"Int J Cancer"},{"key":"10.4065\/82.11.1409_bib240","first-page":"3171","article-title":"Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumors","volume":"61","author":"Hoos","year":"2001","journal-title":"Cancer Res"},{"key":"10.4065\/82.11.1409_bib241","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0046-8177(96)90221-X","article-title":"Desmoid fibromatosis is a clonal process","volume":"27","author":"Li","year":"1996","journal-title":"Hum Pathol"},{"key":"10.4065\/82.11.1409_bib242","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00000478-199703000-00006","article-title":"Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosome inactivation","volume":"21","author":"Lucas","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.4065\/82.11.1409_bib243","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1054\/bjoc.1999.1007","article-title":"Desmoids in familial adenomatous polyposis are monoclonal proliferations","volume":"82","author":"Middleton","year":"2000","journal-title":"Br J Cancer"},{"key":"10.4065\/82.11.1409_bib244","first-page":"60","article-title":"About the fine structure and types of pathological tumors [in German]","author":"Muller","year":"1838","journal-title":"Erste Lieferung"},{"key":"10.4065\/82.11.1409_bib245","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/cncr.11937","article-title":"High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors","volume":"100","author":"Hansmann","year":"2004","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib246","series-title":"Familial Adenomatous Polyposis and Other Polyposis Syndromes","first-page":"128","article-title":"Desmoid disease","author":"Farmer","year":"1994"},{"key":"10.4065\/82.11.1409_bib247","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ajmg.1320280217","article-title":"Occurrence of desmoids in patients with familial adenomatous polyposis of the colon","volume":"28","author":"Klemmer","year":"1987","journal-title":"Am J Med Genet"},{"key":"10.4065\/82.11.1409_bib248","first-page":"167","article-title":"A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum","volume":"3","author":"Gardner","year":"1951","journal-title":"Am J Hum Genet"},{"key":"10.4065\/82.11.1409_bib249","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archsurg.1923.01120010230013","article-title":"Desmoid tumors: a report of 31 cases","volume":"7","author":"Nichols","year":"1923","journal-title":"Arch Surg"},{"key":"10.4065\/82.11.1409_bib250","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02616659","article-title":"Multiple polyposis, Gardner's syndrome and desmoid tumors","volume":"1","author":"Smith","year":"1958","journal-title":"Dis Colon Rectum"},{"key":"10.4065\/82.11.1409_bib251","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/1097-0142(19940815)74:4<1270::AID-CNCR2820740415>3.0.CO;2-7","article-title":"Desmoid tumors in patients with familial adenomatous polyposis","volume":"74","author":"Rodriguez-Bigas","year":"1994","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib252","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lab.2003.10.002","article-title":"Gene expression in aggressive fibromatosis","volume":"143","author":"Skubitz","year":"2004","journal-title":"J Lab Clin Med"},{"key":"10.4065\/82.11.1409_bib253","first-page":"329","article-title":"Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors)","volume":"151","author":"Alman","year":"1997","journal-title":"Am J Pathol"},{"key":"10.4065\/82.11.1409_bib254","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1073\/pnas.102657399","article-title":"beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds","volume":"99","author":"Cheon","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/82.11.1409_bib255","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1034\/j.1399-0004.2000.570306.x","article-title":"A germline mutation at the extreme 3\u2032 end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor","volume":"57","author":"Couture","year":"2000","journal-title":"Clin Genet"},{"key":"10.4065\/82.11.1409_bib256","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/labinvest.3780399","article-title":"Possible association between higher beta-catenin mRNA expression and mutated beta-catenin in sporadic desmoid tumors: real-time semiquantitative assay by TaqMan polymerase chain reaction","volume":"82","author":"Saito","year":"2002","journal-title":"Lab Invest"},{"key":"10.4065\/82.11.1409_bib257","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1038\/sj.onc.1203041","article-title":"Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)","volume":"18","author":"Tejpar","year":"1999","journal-title":"Oncogene"},{"key":"10.4065\/82.11.1409_bib258","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1200\/JCO.2005.04.0717","article-title":"Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor)","volume":"24","author":"Heinrich","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib259","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1902\/jop.2001.72.12.1726","article-title":"Transforming growth factor-beta1 autocrine stimulation regulates fibroblast proliferation in hereditary gingival fibromatosis","volume":"72","author":"de Andrade","year":"2001","journal-title":"J Periodontol"},{"key":"10.4065\/82.11.1409_bib260","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/jor.1100140507","article-title":"Regulation of proliferation and platelet-derived growth factor expression in palmar fibromatosis (Dupuytren contracture) by mechanical strain","volume":"14","author":"Alman","year":"1996","journal-title":"J Orthop Res"},{"key":"10.4065\/82.11.1409_bib261","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1096-9896(199702)181:2<213::AID-PATH739>3.0.CO;2-4","article-title":"Myofibroblasts of palmar fibromatosis co-express transforming growth factor-alpha and epidermal growth factor receptor","volume":"181","author":"Magro","year":"1997","journal-title":"J Pathol"},{"key":"10.4065\/82.11.1409_bib262","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1046\/j.1365-2168.2000.01400.x","article-title":"Surgical management of intra-abdominal desmoid tumours","volume":"87","author":"Smith","year":"2000","journal-title":"Br J Surg"},{"key":"10.4065\/82.11.1409_bib263","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/00000658-199906000-00014","article-title":"The enigma of desmoid tumors","volume":"229","author":"Lewis","year":"1999","journal-title":"Ann Surg"},{"key":"10.4065\/82.11.1409_bib264","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00042737-199910000-00018","article-title":"Treatment of mesenteric desmoid tumours with the anti-oestrogenic agent toremifene: case histories and an overview of the literature","volume":"11","author":"Bus","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.4065\/82.11.1409_bib265","first-page":"475","article-title":"Gardner's syndrome complicated by mesenteric desmoid tumors","volume":"85","author":"Harvey","year":"1979","journal-title":"Surgery"},{"key":"10.4065\/82.11.1409_bib266","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00000658-198607000-00014","article-title":"Desmoid tumors in familial polyposis coli","volume":"204","author":"Jones","year":"1986","journal-title":"Ann Surg"},{"key":"10.4065\/82.11.1409_bib267","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/gut.48.4.515","article-title":"Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families","volume":"48","author":"Friedl","year":"2001","journal-title":"Gut"},{"key":"10.4065\/82.11.1409_bib268","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/1097-0142(20010901)92:5<1259::AID-CNCR1446>3.0.CO;2-Y","article-title":"Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis","volume":"92","author":"Azzarelli","year":"2001","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib269","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0360-3016(98)00285-5","article-title":"Radiation therapy in the management of desmoid tumors","volume":"42","author":"Ballo","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.4065\/82.11.1409_bib270","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/cncr.11029","article-title":"Response of extraabdominal desmoid tumors to therapy with imatinib mesylate","volume":"95","author":"Mace","year":"2002","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib271","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/BF02055435","article-title":"Chemotherapy for desmoid tumors in association with familial adenomatous polyposis","volume":"40","author":"Schnitzler","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"10.4065\/82.11.1409_bib272","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/1097-0142(19890915)64:6<1192::AID-CNCR2820640605>3.0.CO;2-J","article-title":"Low-dose chemotherapy of desmoid tumors","volume":"64","author":"Weiss","year":"1989","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib273","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1200\/JCO.1998.16.9.3021","article-title":"Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children","volume":"16","author":"Skapek","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib274","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1200\/JCO.2005.02.1923","article-title":"Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis","volume":"24","author":"Gega","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1200\/JCO.2005.03.6566","article-title":"Desmoid tumors respond to chemotherapy: defying the dogma in oncology. [editorial]","volume":"24","author":"Patel","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib276","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1002\/1097-0142(19931201)72:11<3244::AID-CNCR2820721118>3.0.CO;2-D","article-title":"Combination chemotherapy in adult desmoid tumors","volume":"72","author":"Patel","year":"1993","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib277","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00000421-199904000-00020","article-title":"Therapy of desmoid tumors and fibromatosis using vinorelbine","volume":"22","author":"Weiss","year":"1999","journal-title":"Am J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib278","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00432-007-0198-9","article-title":"Control of aggressive fibromatosis by treatment with imatinib mesylate: a case report and review of the literature","volume":"133","author":"Wcislo","year":"2007","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.4065\/82.11.1409_bib279","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/jcp.2005.031120","article-title":"Alveolar soft-part sarcoma: a review and update","volume":"59","author":"Folpe","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.4065\/82.11.1409_bib280","series-title":"Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995","year":"1999"},{"key":"10.4065\/82.11.1409_bib281","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.ejca.2006.05.016","article-title":"Childhood soft tissue sarcomas incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project","volume":"42","author":"Pastore","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.4065\/82.11.1409_bib282","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.5858\/2003-127-1290-PFTEOS","article-title":"Protocol for the examination of specimens from patients (children and young adults) with rhabdomyosarcoma","volume":"127","author":"Qualman","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.4065\/82.11.1409_bib283","first-page":"1283","article-title":"Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma","volume":"137","author":"Dias","year":"1990","journal-title":"Am J Pathol"},{"key":"10.4065\/82.11.1409_bib284","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1368-8375(01)00105-1","article-title":"Rhabdomyosarcoma of the head and neck in children","volume":"38","author":"Hicks","year":"2002","journal-title":"Oral Oncol"},{"key":"10.4065\/82.11.1409_bib285","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s100249900076","article-title":"Intergroup Rhabdomyosarcoma Study: update for pathologists","volume":"1","author":"Qualman","year":"1998","journal-title":"Pediatr Dev Pathol"},{"key":"10.4065\/82.11.1409_bib286","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.2002.03.137","article-title":"PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group","volume":"20","author":"Sorensen","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib287","first-page":"5108","article-title":"Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma","volume":"53","author":"Shapiro","year":"1993","journal-title":"Cancer Res"},{"key":"10.4065\/82.11.1409_bib288","first-page":"2869","article-title":"Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma","volume":"54","author":"Davis","year":"1994","journal-title":"Cancer Res"},{"key":"10.4065\/82.11.1409_bib289","first-page":"325","article-title":"Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors","volume":"1","author":"El-Badry","year":"1990","journal-title":"Cell Growth Differ"},{"key":"10.4065\/82.11.1409_bib290","doi-asserted-by":"crossref","first-page":"13264","DOI":"10.1073\/pnas.96.23.13264","article-title":"cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene","volume":"96","author":"Khan","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/82.11.1409_bib291","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1097-0142(19881001)62:7<1257::AID-CNCR2820620703>3.0.CO;2-K","article-title":"Disease patterns and survival rate in children with metastatic soft-tissue sarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS)-I","volume":"62","author":"Raney","year":"1988","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib292","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1200\/JCO.1990.8.3.443","article-title":"Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II","volume":"8","author":"Crist","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib293","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.1995.13.3.610","article-title":"The Third Intergroup Rhabdomyosarcoma Study","volume":"13","author":"Crist","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib294","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1200\/JCO.2001.19.12.3091","article-title":"Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease","volume":"19","author":"Crist","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib295","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/1097-0142(19880115)61:2<209::AID-CNCR2820610202>3.0.CO;2-L","article-title":"The Intergroup Rhabdomyosarcoma Study-I: a final report","volume":"61","author":"Maurer","year":"1988","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib296","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1200\/JCO.2000.18.12.2427","article-title":"Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV","volume":"18","author":"Baker","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib297","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0360-3016(01)01709-6","article-title":"Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma\u2014a report from the IRSG","volume":"51","author":"Donaldson","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.4065\/82.11.1409_bib298","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/1097-0142(19930301)71:5<1904::AID-CNCR2820710530>3.0.CO;2-X","article-title":"The Intergroup Rhabdomyosarcoma Study-II","volume":"71","author":"Maurer","year":"1993","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib299","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.2003.06.129","article-title":"Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma\u2014a report from the Intergroup Rhabdomyosarcoma Study IV","volume":"21","author":"Breneman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib300","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00043426-200105000-00008","article-title":"Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V","volume":"23","author":"Raney","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.4065\/82.11.1409_bib301","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00043426-200106000-00007","article-title":"Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma","volume":"23","author":"Weigel","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.4065\/82.11.1409_bib302","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F","article-title":"Incidence of cancer in children in the United States: sex-, race-, and 1-year age-specific rates by histologic type","volume":"75","author":"Gurney","year":"1995","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib303","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/1097-0142(19921215)70:12<2802::AID-CNCR2820701213>3.0.CO;2-N","article-title":"Malignant transformation in Paget disease of bone","volume":"70","author":"Hadjipavlou","year":"1992","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib304","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jama.1997.03550150066037","article-title":"Cancer incidence after retinoblastoma: radiation dose and sarcoma risk","volume":"278","author":"Wong","year":"1997","journal-title":"JAMA"},{"key":"10.4065\/82.11.1409_bib305","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"key":"10.4065\/82.11.1409_bib306","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0031-3955(05)70540-X","article-title":"Osteosarcoma","volume":"44","author":"Meyers","year":"1997","journal-title":"Pediatr Clin North Am"},{"key":"10.4065\/82.11.1409_bib307","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/cncr.21724","article-title":"Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution","volume":"106","author":"Bacci","year":"2006","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib308","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/cncr.21263","article-title":"Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome\u2014the French pediatric experience","volume":"104","author":"Mialou","year":"2005","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib309","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1080\/17453670610013268","article-title":"Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients","volume":"77","author":"Bacci","year":"2006","journal-title":"Acta Orthop"},{"key":"10.4065\/82.11.1409_bib310","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM198606193142502","article-title":"The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity","volume":"314","author":"Link","year":"1986","journal-title":"N Engl J Med"},{"key":"10.4065\/82.11.1409_bib311","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1200\/JCO.1992.10.10.1579","article-title":"A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup","volume":"10","author":"Bramwell","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib312","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(97)02307-6","article-title":"Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup","volume":"350","author":"Souhami","year":"1997","journal-title":"Lancet"},{"key":"10.4065\/82.11.1409_bib313","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/jnci\/djk015","article-title":"Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup","volume":"99","author":"Lewis","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.4065\/82.11.1409_bib314","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mpo.2950240103","article-title":"Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma Study Group (COSS)","volume":"24","author":"Bielack","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"10.4065\/82.11.1409_bib315","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijrobp.2004.05.051","article-title":"Radiotherapy for local control of osteosarcoma","volume":"61","author":"DeLaney","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.4065\/82.11.1409_bib316","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/1097-0142(197511)36:5<1598::AID-CNCR2820360511>3.0.CO;2-N","article-title":"Adjuvant chemotherapy in primary treatment of osteogenic sarcoma: a Southwest Oncology Group study","volume":"36","author":"Sutow","year":"1975","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib317","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1200\/JCO.1988.6.2.329","article-title":"Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response","volume":"6","author":"Winkler","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib318","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.1998.16.7.2452","article-title":"Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol","volume":"16","author":"Meyers","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib319","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1200\/JCO.2003.08.165","article-title":"Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651","volume":"21","author":"Goorin","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib320","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0022-5223(19)41261-0","article-title":"Pulmonary resection in children with metastatic osteogenic sarcoma: improved survival with surgery, chemotherapy, and irradiation","volume":"75","author":"Giritsky","year":"1978","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.4065\/82.11.1409_bib321","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/cncr.21417","article-title":"Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience","volume":"104","author":"Chou","year":"2005","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib322","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1200\/JCO.20.2.426","article-title":"Phase II\/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial","volume":"20","author":"Goorin","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib323","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00043426-200108000-00004","article-title":"Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial","volume":"23","author":"Ferguson","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.4065\/82.11.1409_bib324","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ijc.21867","article-title":"Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis","volume":"119","author":"Bay","year":"2006","journal-title":"Int J Cancer"},{"key":"10.4065\/82.11.1409_bib325","first-page":"406","article-title":"The effectiveness of chemotherapy in localized malignant fibrous histiocytoma (MFH) of bone: the Rizzoli Institute experience with 66 patients treated with surgery alone or surgery + adjuvant or neoadjuvant chemotherapy","volume":"7","author":"Bacci","year":"1988","journal-title":"Chemioterapia"},{"key":"10.4065\/82.11.1409_bib326","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1200\/JCO.1999.17.10.3260","article-title":"Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: a European Osteosarcoma Intergroup study","volume":"17","author":"Bramwell","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib327","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1200\/JCO.1996.14.2.490","article-title":"The value of high-dose methotrexate-based neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone","volume":"14","author":"Ham","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib328","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<482::AID-CNCR9>3.3.CO;2-E","article-title":"Malignant fibrous histiocytoma of bone: a clinicopathologic study of 81 patients","volume":"79","author":"Nishida","year":"1997","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib329","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejca.2004.08.026","article-title":"Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study","volume":"41","author":"Nooij","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.4065\/82.11.1409_bib330","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1023\/A:1008283516969","article-title":"Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone and in osteosarcoma located in the extremities: analogies and differences between the two tumors","volume":"8","author":"Picci","year":"1997","journal-title":"Ann Oncol"},{"key":"10.4065\/82.11.1409_bib331","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/cncr.2820360925","article-title":"Primary malignant fibrous histiocytoma of bone","volume":"36","author":"Spanier","year":"1975","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib332","first-page":"17","article-title":"Diffuse endothelioma of bone","volume":"12","author":"Ewing","year":"1921","journal-title":"Proc NY Pathol Soc"},{"key":"10.4065\/82.11.1409_bib333","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/jnci\/83.20.1460","article-title":"Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcoma","volume":"83","author":"Smith","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.4065\/82.11.1409_bib334","series-title":"Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995","first-page":"157","article-title":"Cancer among adolescents 15-19 years old","author":"Smith","year":"1999"},{"key":"10.4065\/82.11.1409_bib335","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.ejca.2006.05.015","article-title":"Bone tumours in European children and adolescents, 1978-1997: report from the Automated Childhood Cancer Information System Project","volume":"42","author":"Stiller","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.4065\/82.11.1409_bib336","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ijc.2910530305","article-title":"International variations in the incidence of childhood bone tumours","volume":"53","author":"Parkin","year":"1993","journal-title":"Int J Cancer"},{"key":"10.4065\/82.11.1409_bib337","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1200\/JCO.2000.18.1.204","article-title":"Molecular biology of the Ewing's sarcoma\/primitive neuroectodermal tumor family","volume":"18","author":"de Alava","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib338","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/1097-0142(19910401)67:7<1886::AID-CNCR2820670712>3.0.CO;2-U","article-title":"MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors: evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration","volume":"67","author":"Ambros","year":"1991","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib339","first-page":"317","article-title":"Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30\/ 32MIC2","volume":"139","author":"Fellinger","year":"1991","journal-title":"Am J Pathol"},{"key":"10.4065\/82.11.1409_bib340","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/359162a0","article-title":"Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours","volume":"359","author":"Delattre","year":"1992","journal-title":"Nature"},{"key":"10.4065\/82.11.1409_bib341","first-page":"257","article-title":"The ETS oncogene family in development, proliferation and neoplasia","volume":"59","author":"Hromas","year":"1994","journal-title":"Int J Hematol"},{"key":"10.4065\/82.11.1409_bib342","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0165-4608(96)00326-3","article-title":"Multiple chromosomal mechanisms generate an EWS\/FLI1 or an EWS\/ERG fusion gene in Ewing tumors","volume":"97","author":"Desmaze","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.4065\/82.11.1409_bib343","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ng0893-341","article-title":"EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts","volume":"4","author":"Zucman","year":"1993","journal-title":"Nat Genet"},{"key":"10.4065\/82.11.1409_bib344","first-page":"2837","article-title":"Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor","volume":"54","author":"Ladanyi","year":"1994","journal-title":"Cancer Res"},{"key":"10.4065\/82.11.1409_bib345","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/gcc.2870120412","article-title":"Fusion of the EWS gene to a DNA segment from 9q22-31 in a human myxoid chondrosarcoma","volume":"12","author":"Gill","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.4065\/82.11.1409_bib346","first-page":"345","article-title":"Ewing's sarcoma of the bone: anatomoclinical study of 424 cases [in Italian]","volume":"44","author":"Bacci","year":"1992","journal-title":"Minerva Pediatr"},{"key":"10.4065\/82.11.1409_bib347","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.mnm.0000186608.12895.69","article-title":"Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours","volume":"27","author":"Gyorke","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.4065\/82.11.1409_bib348","doi-asserted-by":"crossref","first-page":"8828","DOI":"10.1200\/JCO.2005.01.7079","article-title":"[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors","volume":"23","author":"Hawkins","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib349","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/pbc.20754","article-title":"An analysis of primary site control and late effects according to local control modality in non-metastatic Ewing sarcoma","volume":"48","author":"Paulino","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.4065\/82.11.1409_bib350","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0360-3016(02)03797-5","article-title":"Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials","volume":"55","author":"Schuck","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.4065\/82.11.1409_bib351","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1200\/JCO.2006.05.9188","article-title":"Local control in pelvic Ewing sarcoma: analysis from INT-0091\u2014a report from the Children's Oncology Group","volume":"24","author":"Yock","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib352","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/1097-0142(197105)27:5<1051::AID-CNCR2820270508>3.0.CO;2-7","article-title":"Altered pattern of metastasis following treatment of Ewing's sarcoma with radiotherapy and adjuvant chemotherapy","volume":"27","author":"Marsa","year":"1971","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib353","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/1097-0142(197611)38:5<1925::AID-CNCR2820380510>3.0.CO;2-J","article-title":"Improved outlook for Ewing's sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy","volume":"38","author":"Jaffe","year":"1976","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib354","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.1990.8.10.1664","article-title":"Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study","volume":"8","author":"Nesbit","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib355","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.1990.8.9.1514","article-title":"Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II","volume":"8","author":"Burgert","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib356","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJMoa020890","article-title":"Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone","volume":"348","author":"Grier","year":"2003","journal-title":"N Engl J Med"},{"key":"10.4065\/82.11.1409_bib357","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1179\/joc.1998.10.6.484","article-title":"Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity","volume":"10","author":"Ferrari","year":"1998","journal-title":"J Chemother"},{"key":"10.4065\/82.11.1409_bib358","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1200\/JCO.2000.18.17.3108","article-title":"Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group","volume":"18","author":"Cotterill","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib359","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1200\/JCO.1998.16.9.3044","article-title":"Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients","volume":"16","author":"Paulussen","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.4065\/82.11.1409_bib360","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0360-3016(88)90346-X","article-title":"High-risk Ewing's sarcoma: end-intensification using autologous bone marrow transplantation","volume":"15","author":"Marcus","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl 2","key":"10.4065\/82.11.1409_bib361","first-page":"95","article-title":"Improved relapse free survival in patients with poor prognosis Ewing's sarcoma after consolidation with hyperfractionated total body irradiation and fractionated high dose melphalan followed by high dose etoposide and hematopoietic rescue","volume":"7","author":"Burdach","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.4065\/82.11.1409_bib362","first-page":"284","article-title":"High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma: (EI)CESS [in German]","volume":"211","author":"Frohlich","year":"1999","journal-title":"Klin Padiatr"},{"key":"10.4065\/82.11.1409_bib363","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00043426-200202000-00009","article-title":"Irinotecan for pediatric solid tumors: the Memorial Sloan-Kettering experience","volume":"24","author":"Cosetti","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.4065\/82.11.1409_bib364","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/pbc.20697","article-title":"Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma","volume":"48","author":"Wagner","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.4065\/82.11.1409_bib365","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2407-7-46","article-title":"Giant cell tumor of the uterus: case report and response to chemotherapy","volume":"7","author":"Skubitz","year":"2007","journal-title":"BMC Cancer"},{"key":"10.4065\/82.11.1409_bib366","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1542\/peds.103.6.1282","article-title":"Interferon and giant cell tumors","volume":"103","author":"Dickerman","year":"1999","journal-title":"Pediatrics"},{"key":"10.4065\/82.11.1409_bib367","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1210\/endo-91-4-916","article-title":"Congenital osteopetrosis in mice cured by parabiotic union with normal siblings","volume":"91","author":"Walker","year":"1972","journal-title":"Endocrinology"},{"key":"10.4065\/82.11.1409_bib368","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1126\/science.1198094","article-title":"Spleen cells transmit osteopetrosis in mice","volume":"190","author":"Walker","year":"1975","journal-title":"Science"},{"key":"10.4065\/82.11.1409_bib369","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1097-4644(19980701)70:1<121::AID-JCB12>3.0.CO;2-S","article-title":"Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: possible involvement in CD68+ macrophage-like cell migration","volume":"70","author":"Zheng","year":"1998","journal-title":"J Cell Biochem"},{"key":"10.4065\/82.11.1409_bib370","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0002-9440(10)62959-8","article-title":"Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB","volume":"167","author":"Morgan","year":"2005","journal-title":"Am J Pathol"},{"key":"10.4065\/82.11.1409_bib371","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.lab.2004.06.005","article-title":"Gene expression in giant-cell tumors","volume":"144","author":"Skubitz","year":"2004","journal-title":"J Lab Clin Med"},{"key":"10.4065\/82.11.1409_bib372","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1309\/BPET-F2PE-P2BD-J3P3","article-title":"RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone","volume":"117","author":"Roux","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/82.11.1409_bib373","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI112838","article-title":"Human giant cell tumors of bone identification and characterization of cell types","volume":"79","author":"Goldring","year":"1987","journal-title":"J Clin Invest"},{"key":"10.4065\/82.11.1409_bib374","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/path.1711470302","article-title":"An immunohistological study of giant-cell tumour of bone: evidence for an osteoclast origin of the giant cells","volume":"147","author":"Athanasou","year":"1985","journal-title":"J Pathol"},{"key":"10.4065\/82.11.1409_bib375","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.4065\/82.11.1409_bib376","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0002-9440(10)64942-5","article-title":"Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation","volume":"156","author":"Huang","year":"2000","journal-title":"Am J Pathol"},{"key":"10.4065\/82.11.1409_bib377","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1359\/jbmr.2000.15.4.640","article-title":"Expression of osteoclast differentiation signals by stromal elements of giant cell tumors","volume":"15","author":"Atkins","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.4065\/82.11.1409_bib378","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.blo.0000141372.54456.80","article-title":"Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis","author":"Chang","year":"2004","journal-title":"Clin Orthop Relat Res"},{"key":"10.4065\/82.11.1409_bib379","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00223-004-0120-2","article-title":"Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone","volume":"75","author":"Cheng","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.4065\/82.11.1409_bib380","series-title":"WHO Classification of Tumors, Pathology and Genetics, Tumors of Soft Tissue and Bone","first-page":"310","article-title":"Giant cell tumor","author":"Reid","year":"2002"},{"key":"10.4065\/82.11.1409_bib381","first-page":"116","article-title":"Giant cell tumor of tendon sheath","volume":"34","author":"Walsh","year":"2005","journal-title":"Am J Orthop"},{"key":"10.4065\/82.11.1409_bib382","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0046-8177(97)90155-6","article-title":"Giant cell tumor of tendon sheath is a polyclonal cellular proliferation","volume":"28","author":"Vogrincic","year":"1997","journal-title":"Hum Pathol"},{"key":"10.4065\/82.11.1409_bib383","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00428-002-0640-y","article-title":"Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumors","volume":"441","author":"Nilsson","year":"2002","journal-title":"Virchows Arch"},{"key":"10.4065\/82.11.1409_bib384","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/1097-0142(19920201)69:3<662::AID-CNCR2820690311>3.0.CO;2-I","article-title":"Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma","volume":"69","author":"Casson","year":"1992","journal-title":"Cancer"},{"key":"10.4065\/82.11.1409_bib385","first-page":"835","article-title":"Pulmonary metastasectomy for soft tissue sarcomas: is it valuable?","volume":"42","author":"Belal","year":"2001","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.4065\/82.11.1409_bib386","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/00000658-199905000-00002","article-title":"Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival","volume":"229","author":"Billingsley","year":"1999","journal-title":"Ann Surg"},{"key":"10.4065\/82.11.1409_bib387","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/oxfordjournals.annonc.a057746","article-title":"Results of salvage surgery for metastatic sarcomas","volume":"1","author":"Pastorino","year":"1990","journal-title":"Ann Oncol"},{"key":"10.4065\/82.11.1409_bib388","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9610(05)81150-X","article-title":"Aggressive metastasectomy for pulmonic sarcomatous metastases: a follow-up study","volume":"166","author":"Saltzman","year":"1993","journal-title":"Am J Surg"},{"key":"10.4065\/82.11.1409_bib389","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/stcs.2002.31892","article-title":"The role of pulmonary metastasectomy in soft tissue sarcoma","volume":"14","author":"Temple","year":"2002","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.4065\/82.11.1409_bib390","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2164-8-73","article-title":"Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential","volume":"8","author":"Francis","year":"2007","journal-title":"BMC Genomics"},{"key":"10.4065\/82.11.1409_bib391","doi-asserted-by":"crossref","first-page":"7201","DOI":"10.1158\/0008-5472.CAN-04-1673","article-title":"A gene expression signature associated with metastatic outcome in human leiomyosarcomas","volume":"64","author":"Lee","year":"2004","journal-title":"Cancer Res"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611614213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611614213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:59:03Z","timestamp":1738889943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611614213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":391,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0025619611614213"],"URL":"https:\/\/doi.org\/10.4065\/82.11.1409","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}